AI CuratorAI-generated
Research summary · AI summary · not yet reviewedSubjects not reportedSystematic reviewPeer-reviewed
Mesenchymal Stem Cell Transplantation in Progressive Multiple Sclerosis: A Systematic Review
A systematic review assessed the efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis. It was identified as a correction to previous findings, indicating an update rather than new data.
- Most relevant to
- Neurologist, Immunologist
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
This review reflects ongoing research into optimizing treatment strategies for progressive multiple sclerosis, which is critical for effective patient care.
What this does not prove
The study does not present new data on the efficacy or safety of the treatment, only correcting earlier findings without additional evidence.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Yes
- Controlled
- Yes
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-11
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Other
Original sources
- Primary evidenceEfficacy of Stem Cell Therapy for Progressive MS ↗
Supporting passages (9)
study designTitle: Correction: Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization.
randomizedrandomized controlled trials
controlledrandomized controlled trials
peer reviewedJournal: Frontiers in immunology
research categoriesclinical implications for patient stratification and treatment optimization.
publication datePublication date: 2026-09-11
interventionmesenchymal stem cell transplantation
findingsTitle: Correction: Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization.
limitationsTitle: Correction: Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.